MANKIND closed at ₹2,327.90 on Sep 4, 2026. Mankind Pharma Limited (MANKIND) trades on NSE/BSE. Market capitalisation is ₹96,141 Cr. The trailing P/E ratio is 47.04. It operates in the Healthcare sector.
MANKIND, Upmazing Score 53/100
Mankind Pharma Limited (NSE: MANKIND) scores 53 on Upmazing’s scoring engine, read from two independent layers: fundamentals filed with the exchange and end-of-day technicals. Below: each signal layer and the numbers behind it, marked with their sources.
Not built yetAI synthesis — not built yetOne paragraph that fuses MANKIND's latest filings with its price structure. Not built yet — nothing behind this card generates it today.
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 1, 2026 · BSE · raw filing ↗
About & managementfrom filings & exchange disclosures
Mankind Pharma Limited is a large-cap healthcare company traded on the NSE and BSE, and a constituent of NIFTY Midcap 150. It trades in the F&O segment (lot size 250).
Coming soon
Company facts (founded, HQ, employees) and the board / KMP roster with tenures arrive with the company-profile source.
Interim Dividend - Re 1 Per Shareex-date Aug 8, 2025 · record Aug 8, 2025
What if you'd invested?EOD closes
MANKIND doesn't have 5Y of listed history yet — the calculator unlocks as price history accrues.
Past EOD returns redistributed — not a projection. LTCG shown at 12.5% beyond the ₹1.25 L/yr exemption (FY26 rules), indicative only, not tax advice; SIP units have mixed holding periods.
Frequently asked
auto-built per stock · FAQ schema
Once MANKIND's end-of-day history is ingested, this page shows its official exchange close, refreshed after each trading session, with the full price history on the Chart tab (split- and bonus-adjusted for NSE-primary series; BSE-primary series are shown as-traded). Upmazing does not stream live quotes, so every price-linked figure is anchored to the last close.
Where enough filed data exists, MANKIND carries an Upmazing Score, a 0-100 standing computed from its real fundamentals (growth, margins, leverage, returns) and end-of-day technicals. The Score tab breaks down every component, and says plainly when one can't be computed.
After each session with price data on record, MANKIND runs through Upmazing's end-of-day scanner library, covering momentum, trend, volatility, volume and fundamental checks. Scanners that fired on the latest session are listed on the Patterns tab with the exact rule each fired on.
Declared dividends, ex-dates and bonus or split history for MANKIND come from corporate-action records and appear here as they are ingested. Dividend yield is computed on trailing-12-month dividends at the last close.
Comparable companies for MANKIND are grouped by sector, then compared on revenue growth, ROE, ROCE, debt-to-equity and margins. The Peers tab shows the full side-by-side table, and where a sector is classified, the sector peers panel on this page links the largest sector-mates.
Market cap for MANKIND is computed from shares outstanding in the filed balance sheet, priced at the last close, and refreshed after each session. Where the balance-sheet input or a last close is missing, the cell shows a dash rather than an estimate.
The trailing 52-week high and low for MANKIND are derived from its end-of-day price history and appear in the key statistics on this page once a full year of sessions is on record. The full price chart lives on the Chart tab.
The filed balance sheet for MANKIND is presented on the Financials tab; for non-lenders that includes debt-to-equity, while banks and NBFCs read leverage through banking ratios instead.
Where MANKIND's shareholding pattern has been ingested, the Holdings tab tracks promoter, FII, mutual-fund, DII and public holding plus any promoter pledge, quarter by quarter from the disclosed filings.
Prices are official exchange end-of-day closes, refreshed after each trading session. Fundamentals, shareholding and corporate actions for MANKIND are parsed from official filings — quarterly results, shareholding disclosures and corporate-action records — as they are published.
Filed results · consolidated · audited·as of Q1 2026-27partial data
Frequently Asked Questions
What is Mankind Pharma Limited's share price today?
Mankind Pharma Limited (MANKIND) closed at ₹2,327.90 on 2026-09-04.
Which sector does Mankind Pharma Limited belong to?
Mankind Pharma Limited is classified under sector 'Healthcare' per NSE's 4-tier classification.
What is Mankind Pharma Limited's PE ratio?
Mankind Pharma Limited's trailing PE ratio is 47.0x based on the latest filed earnings and market close.
